{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:10:26Z","timestamp":1789596626875,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4201,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Oncostatin M (OSM) is a member of the IL-6 family of cytokines. Mice deficient in the OSM receptor (OSMR<jats:sup>-\/-<\/jats:sup>) showed impaired liver regeneration with persistent parenchymal necrosis after carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) exposure. The recovery of liver mass from partial hepatectomy was also significantly delayed in OSMR<jats:sup>-\/-<\/jats:sup> mice. In contrast to wildtype mice, CCl<jats:sub>4<\/jats:sub> administration only marginally induced expression of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 genes in OSMR<jats:sup>-\/-<\/jats:sup> mice, correlating with the increased gelatinase activity of matrix metalloproteinase (MMP)-9 and matrix degradation in injured livers. The activation of STAT3 and expression of immediate early genes and cyclins were decreased in OSMR<jats:sup>-\/-<\/jats:sup> liver, indicating that OSM signaling is required for hepatocyte proliferation and tissue remodeling during liver regeneration. We also found that CCl<jats:sub>4<\/jats:sub> administration in IL-6<jats:sup>-\/-<\/jats:sup> mice failed to induce OSM expression and that OSM administration in IL-6<jats:sup>-\/-<\/jats:sup> mice after CCl<jats:sub>4<\/jats:sub> injection induced the expression of cyclin D1 and proliferating cell nuclear antigen, suggesting that OSM is a key mediator of IL-6 in liver regeneration. Consistent with these results, administration of OSM ameliorated liver injury in wildtype mice by preventing hepatocyte apoptosis as well as tissue destruction. In conclusion, OSM and its signaling pathway may provide a useful therapeutic target for liver regeneration. (Hepatology 2004;39:635-644.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.20086","type":"journal-article","created":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T08:02:00Z","timestamp":1078128120000},"page":"635-644","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":137,"title":["Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice"],"prefix":"10.1097","volume":"39","author":[{"given":"Koji","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20241201","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1096\/fasebj.9.15.8529831","article-title":"Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration.","volume":"9","author":"Fausto","year":"1995","journal-title":"FASEB J"},{"key":"R2-11-20241201","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.276.5309.60","article-title":"Liver regeneration.","volume":"276","author":"Michalopoulos","year":"1997","journal-title":"Science"},{"key":"R3-11-20241201","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/hep.1840130422","article-title":"Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration.","volume":"13","author":"Lindroos","year":"1991","journal-title":"HEPATOLOGY"},{"key":"R4-11-20241201","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1073\/pnas.79.3.776","article-title":"Alteration of epidermal growth factor-dependent phosphorylation during rat liver regeneration.","volume":"79","author":"Rubin","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-11-20241201","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/hep.1840180622","article-title":"Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor.","volume":"18","author":"Webber","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R6-11-20241201","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1073\/pnas.86.5.1558","article-title":"Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism.","volume":"86","author":"Mead","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-11-20241201","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1073\/pnas.94.4.1441","article-title":"Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.","volume":"94","author":"Yamada","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-11-20241201","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/hep.510280410","article-title":"Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.","volume":"28","author":"Yamada","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R9-11-20241201","first-page":"1577","article-title":"Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor.","volume":"152","author":"Yamada","year":"1998","journal-title":"Am J Pathol"},{"key":"R10-11-20241201","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/hep.510280509","article-title":"Tumor necrosis factor primes hepatocytes for DNA replication in the rat.","volume":"28","author":"Webber","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R11-11-20241201","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","article-title":"Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.","volume":"274","author":"Cressman","year":"1996","journal-title":"Science"},{"key":"R12-11-20241201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510310123","article-title":"Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice.","volume":"31","author":"Kovalovich","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R13-11-20241201","doi-asserted-by":"crossref","first-page":"28411","DOI":"10.1074\/jbc.M202807200","article-title":"STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration.","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"R14-11-20241201","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1074\/jbc.M100740200","article-title":"Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.","volume":"276","author":"Kovalovich","year":"2001","journal-title":"J Biol Chem"},{"key":"R15-11-20241201","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI200317970","article-title":"Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.","volume":"112","author":"Haga","year":"2003","journal-title":"J Clin Invest"},{"key":"R16-11-20241201","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0024-3205(99)00296-9","article-title":"Oncostatin M: signal transduction and biological activity.","volume":"65","author":"Gomez-Lechon","year":"1999","journal-title":"Life Sci"},{"key":"R17-11-20241201","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp130 and the interleukin-6 family of cytokines.","volume":"15","author":"Taga","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R18-11-20241201","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1359-6101(00)00003-4","article-title":"Role of Oncostatin M in hematopoiesis and liver development.","volume":"11","author":"Miyajima","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"R19-11-20241201","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood.V93.3.804","article-title":"Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.","volume":"93","author":"Tanaka","year":"1999","journal-title":"Blood"},{"key":"R20-11-20241201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80463-X","article-title":"In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region.","volume":"8","author":"Mukouyama","year":"1998","journal-title":"Immunity"},{"key":"R21-11-20241201","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/dbio.1998.8990","article-title":"Kogo,H, Donovan PJ, et al. Distinct roles of oncostatin M and leukemia inhibitory factor in the development of primordial germ cells and Sertoli cells in mice.","volume":"201","author":"Hara","year":"1998","journal-title":"Dev Biol"},{"key":"R22-11-20241201","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.96.13.7265","article-title":"Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis.","volume":"96","author":"Kinoshita","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-11-20241201","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/emboj\/18.8.2127","article-title":"Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.","volume":"18","author":"Kamiya","year":"1999","journal-title":"EMBO J"},{"key":"R24-11-20241201","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/bbrc.2000.3635","article-title":"Cell density-dependent regulation of hepatic development by a gp130-independent pathway.","volume":"277","author":"Kojima","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R25-11-20241201","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.4049\/jimmunol.148.6.1731","article-title":"Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro.","volume":"148","author":"Richards","year":"1992","journal-title":"J Immunol"},{"key":"R26-11-20241201","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840180624","article-title":"Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures.","volume":"18","author":"Roeb","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R27-11-20241201","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.4049\/jimmunol.150.12.5596","article-title":"Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture.","volume":"150","author":"Richards","year":"1993","journal-title":"J Immunol"},{"key":"R28-11-20241201","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.159.5.2431","article-title":"Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6.","volume":"159","author":"Richards","year":"1997","journal-title":"J Immunol"},{"key":"R29-11-20241201","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1074\/jbc.273.9.5211","article-title":"Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter.","volume":"273","author":"Botelho","year":"1998","journal-title":"J Biol Chem"},{"key":"R30-11-20241201","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/107999099313145","article-title":"Adenovirus vector expressing mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice.","volume":"10","author":"Kerr","year":"1999","journal-title":"J Interferon Cytokine Res"},{"issue":"Suppl 1","key":"R31-11-20241201","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(00)80412-2","article-title":"Liver regeneration.","volume":"32","author":"Fausto","year":"2000","journal-title":"J Hepatol"},{"key":"R32-11-20241201","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s004180000150","article-title":"Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.","volume":"113","author":"Knittel","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"R33-11-20241201","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2003-02-0367","article-title":"Targeted disruption of Oncostatin M receptor results in altered hematopoiesis.","volume":"102","author":"Tanaka","year":"2003","journal-title":"Blood"},{"key":"R34-11-20241201","first-page":"186","article-title":"Experimental pathology of the liver. I. Restoration of the liver of the white rat following surgical removal.","volume":"12","author":"Higgins","year":"1931","journal-title":"Arch Pathol"},{"key":"R35-11-20241201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells.","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol"},{"key":"R36-11-20241201","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/209036a0","article-title":"Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation.","volume":"209","author":"Slater","year":"1966","journal-title":"Nature"},{"key":"RU37-11-20241201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)65594-0","article-title":"Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride.","volume":"153","author":"Shi","year":"1998","journal-title":"Am J Pathol"},{"key":"R38-11-20241201","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0168-8278(97)80266-8","article-title":"Liver regeneration: methods for monitoring and their applications.","volume":"26","author":"Assy","year":"1997","journal-title":"J Hepatol"},{"key":"R39-11-20241201","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/jhep.2001.22650","article-title":"Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.","volume":"33","author":"Shimizu","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R40-11-20241201","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/hep.1840210531","article-title":"Rapid activation of the Stat3 transcription complex in liver regeneration.","volume":"21","author":"Cressman","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R41-11-20241201","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/hep.510300502","article-title":"Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats.","volume":"30","author":"Rudolph","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R42-11-20241201","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/0016-5085(95)90149-3","article-title":"Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor.","volume":"108","author":"Czaja","year":"1995","journal-title":"Gastroenterology"},{"key":"R43-11-20241201","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm1101-1202","article-title":"Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.","volume":"7","author":"Wielockx","year":"2001","journal-title":"Nat Med"},{"key":"R44-11-20241201","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/1529-0131(200112)44:12<2888::AID-ART477>3.0.CO;2-3","article-title":"Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice.","volume":"44","author":"Schett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R45-11-20241201","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.4049\/jimmunol.162.9.5547","article-title":"Regulation of inflammatory responses by oncostatin M.","volume":"162","author":"Wallace","year":"1999","journal-title":"J Immunol"},{"key":"R46-11-20241201","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1074-7613(00)80501-4","article-title":"Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.","volume":"5","author":"Fukada","year":"1996","journal-title":"Immunity"},{"key":"R47-11-20241201","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1074\/jbc.M100740200","article-title":"Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.","volume":"276","author":"Kovalovich","year":"2001","journal-title":"J Biol Chem"},{"key":"R48-11-20241201","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1074\/jbc.M208470200","article-title":"Interleukin-6glycoprotein 130-dependent pathways are protective during liver regeneration.","volume":"268","author":"Wuestefeld","year":"2003","journal-title":"J Biol Chem"},{"key":"R49-11-20241201","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.RES.85.12.1124","article-title":"Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1beta.","volume":"85","author":"Bernard","year":"1999","journal-title":"Circ Res"},{"key":"R50-11-20241201","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.147.7.2175","article-title":"Regulation of IL-6 expression by oncostatin M.","volume":"147","author":"Brown","year":"1991","journal-title":"J Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200403000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:05:35Z","timestamp":1733054735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200403000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20086","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}